# Clinical Application and Usability of Blood Biomarkers As Screening Tool in Alzheimer Disease: a Validation Study

> **NCT06699992** · — · NOT_YET_RECRUITING · sponsor: **Fondazione Policlinico Universitario Agostino Gemelli IRCCS** · enrollment: 1000 (estimated)

## Conditions studied

- Cognitive Decline

## Interventions

- **DIAGNOSTIC_TEST:** Blood biomarkers quantification

## Key facts

- **NCT ID:** NCT06699992
- **Lead sponsor:** Fondazione Policlinico Universitario Agostino Gemelli IRCCS
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2024-12-01
- **Primary completion:** 2026-08
- **Final completion:** 2026-08
- **Target enrollment:** 1000 (ESTIMATED)
- **Last updated:** 2024-11-21

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06699992

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06699992, "Clinical Application and Usability of Blood Biomarkers As Screening Tool in Alzheimer Disease: a Validation Study". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT06699992. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*